Evaluation of the Metabolic Parameters in Women with Gestational Diabetes Mellitus after Delivery: A Comparative Study

Abstract

Most of the women with GDM have clinical manifestations indicating a risk for type 2 diabetes (T2D). Present evidence signifies that T2D can be withhold or delayed by intensive lifestyle adjustments and through medications, predominantly those that ameliorate insulin resistance. Glucose tolerance test in the postpartum period to detect diabetes or evaluate diabetes risk is the mandatory clinical management step. All patients should be properly monitored for increasing glycemia indicative of progressive \(\beta\)-cell deterioration. Combination of fasting glucose and glycosylated hemoglobin measurements are suggested for this purpose. Monitoring should be instigated at least annually and should be continued frequently if glycemia is rising and/or impaired. Lifestyle alterations are recommended to diminish the risk for T2D. Breastfeeding is also very essential for the profound short-term and long-term health benefits of the infant, encouragement and facilitation to the breastfeeding women reduces the risks for subsequent obesity and glucose intolerance also